Skip to main content
SpringerLink
Log in

Professor Sjöström’s reply

  • Correspondence
  • Published:
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lindgarde F.: The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: the Swedish Multimorbidity Study. J. Intern. Med., 248, 245–254, 2000.

    Article  CAS  PubMed  Google Scholar 

  2. Finer N., James W.P., Kopelman P.G., Lean M.E., Williams G.: One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor. Int. J. Obes., 24, 306–313, 2000.

    Article  CAS  Google Scholar 

  3. Rossner S., Sjöström L., Noack R., Meinders A.E., Noseda G.: Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. Obes. Res., 8, 49–61, 2000.

    Article  CAS  PubMed  Google Scholar 

  4. Hauptman J., Lucas C., Boldrin M.N., Collins H., Segal K.R.: Orlistat in the long-term treatment of obesity in primary care settings. Arch. Fam. Med., 9, 160–167, 2000.

    Article  CAS  PubMed  Google Scholar 

  5. Micic D., Ivkovic-Lazar T., Dragojevic R., Jorga J., Stokic E., Hajdukovic Z.: Orlistat, a gastrointestinal lipase inhibitor, in therapy of obesity with concomitant hyperlipidemia. Med. Pregl., 52, 323–333, 1999.

    CAS  PubMed  Google Scholar 

  6. Hill J.O., Hauptman J., Anderson J.W., Fujioka K., O’Neil P.M., Smith D.K., Zavoral J.H., Aronne L.J.: Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study. Am. J. Clin. Nutr., 69, 1108–1116, 1999.

    CAS  PubMed  Google Scholar 

  7. Hollander P.A., Elbein S.C., Hirsch I.B., Kelley D., McGill J., Taylor T., Weiss S.R., Crockett S.E., Kaplan R.A., Comstock J., Lucas C.P., Lodewick P.A., Canovatchel W., Chung J., Hauptman J.: Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. Diabetes Care, 21, 1288–1294, 1998.

    Article  CAS  PubMed  Google Scholar 

  8. Van Gaal L.F., Broom J.I., Enzi G., Toplak H.: Efficacy and tolerability of orlistat in the treatment of obesity: a 6-month dose-ranging study. Orlistat Dose-Ranging Study Group. Eur. J. Clin. Pharmacol., 54, 125–132, 1998.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sahlgrenska University Hospital, Göteborg, Sweden

    L. Sjöström

Authors
  1. L. Sjöström
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sjöström, L. Professor Sjöström’s reply. Eat Weight Disord 6, 172–173 (2001). https://doi.org/10.1007/BF03339768

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03339768

Keywords

Search

Navigation